<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04151173</url>
  </required_header>
  <id_info>
    <org_study_id>ShanghaiFMIH Jing Sun</org_study_id>
    <nct_id>NCT04151173</nct_id>
  </id_info>
  <brief_title>Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma</brief_title>
  <official_title>Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai First Maternity and Infant Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Peace Maternity and Child Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Tongji Hospital, Tongji University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai First Maternity and Infant Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicentric (three centers: 1: Shanghai First Maternity and Infant&#xD;
      Hospital, Shanghai, China; 2: International Peace Maternity and Child Health Hospital,&#xD;
      Shanghai, China, 3: Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai&#xD;
      ,China), randomized clinical trial that includes patients undergoing laparoscopic surgery for&#xD;
      primary unilateral ovarian endometriomas. Eligible patients will be subjected to transvaginal&#xD;
      ultrasound before surgery to perform cyst classification (central type, marginal type and&#xD;
      outcrop type). Patients are divided to two group: laparoscopic cystectomy group versus&#xD;
      laparoscopic aspiration/electrocoagulation group. Biopsy samples in&#xD;
      aspiration/electrocoagulation group and excision samples in cystectomy group are all&#xD;
      subjected to histopathological examination. Follicular stimulating hormone (FSH), Anti&#xD;
      mullerian hormone (AMH) and antral follicular count (AFC) will be measured pre-operative and&#xD;
      post-operative.&#xD;
&#xD;
      The aim of the study is to determine whether and to what extent the two surgical procedures&#xD;
      for ovarian endometrioma, cystectomy and aspiration/electrocoagulation, affect ovarian&#xD;
      reserve. The investigators intend to confirm the clinical utility of ultrasonic&#xD;
      classification of ovarian endometrioma, FSH, AMH and AFC in the assessment of ovarian&#xD;
      reserve, and to promote their use in predicting decreased ovarian reserve.&#xD;
&#xD;
      The surgical excision of cystic wall, cystic fluid and peritoneal fluid will be subjected to&#xD;
      transmission electron microscope, high resolution mass spectrometry and single-cell RNA&#xD;
      sequencing to investigate their cellular and molecular features.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>comparison between the impacts of laparoscopic cystectomy and laparoscopic aspiration /electrocoagulation on ovarian reserve as determined by alteration of AFC estimation in endometrioma patients.</measure>
    <time_frame>6 months</time_frame>
    <description>AFC: number of follicles with average diameter of 2-10 mm in both ovaries assessed on day 2-5 of the menstrual cycle.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison between the impacts of laparoscopic cystectomy and laparoscopic aspiration /electrocoagulation on ovarian reserve as determined by alteration of AMH level in endometrioma patients.</measure>
    <time_frame>6 months</time_frame>
    <description>AMH is assessed on venous blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparison between the impacts of laparoscopic cystectomy and laparoscopic aspiration /electrocoagulation on ovarian reserve as determined by alteration of FSH level in endometrioma patients.</measure>
    <time_frame>6 months</time_frame>
    <description>FSH is assessed on venous blood samples obtained on day 2-5 of the menstrual cycle</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Ultrasonic classification of ovarian endometrioma</measure>
    <time_frame>Baseline (before laparoscopy)</time_frame>
    <description>preoperative transvaginal ultrasonic classification of ovarian endometrioma (central type, marginal type and outcrop type)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ovarian Endometrioma</condition>
  <condition>Ovarian Reserve</condition>
  <arm_group>
    <arm_group_label>aspiration/electrocoagulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>cystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic aspiration/electrocoagulation</intervention_name>
    <description>laparoscopic aspiration/electrocoagulation of ovarian endometrioma</description>
    <arm_group_label>aspiration/electrocoagulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic cystectomy</intervention_name>
    <description>laparoscopic cystectomy of ovarian endometrioma</description>
    <arm_group_label>cystectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female with age between 18-40 years.&#xD;
&#xD;
          -  Regular menstrual cycles&#xD;
&#xD;
          -  Female diagnosed by ultrasound with unilateral ovarian endometrioma ≥4cm and ≤6cm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hormone, Gonadotropin-releasing hormone analogues or contraceptive therapy within 6&#xD;
             months before the current surgery and 6 months after surgery.&#xD;
&#xD;
          -  Suspected or proven ovarian malignancy.&#xD;
&#xD;
          -  Previous ovarian surgery.&#xD;
&#xD;
          -  Evidence of polycystic ovary syndrome.&#xD;
&#xD;
          -  Evidence of premature ovarian failure or premature menopause.&#xD;
&#xD;
          -  Endocrinological diseases affecting ovarian reserve e.g. Diabetes mellitus,&#xD;
             hypothyroidism.&#xD;
&#xD;
          -  Pregnancy test is positive.&#xD;
&#xD;
          -  Lactation.&#xD;
&#xD;
          -  Unable or unwilling to give written consent.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jing Sun</last_name>
    <phone>86-021-20261258</phone>
    <email>sunjing61867@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai First Maternity and Infant Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jing Sun</last_name>
      <phone>86-021-20261258</phone>
      <email>sunjing61867@126.com</email>
    </contact>
    <investigator>
      <last_name>Weilin Tan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 30, 2019</study_first_submitted>
  <study_first_submitted_qc>November 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2019</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

